Morgan Stanley says Salesforce (CRM) Q2 results, while ahead of consensus, were largely inline with buyside expectations and “alone are unlikely to prove an upward catalyst.” However, the firm can see “the pieces coming together for a more positive trajectory in growth and a solid catalyst path ahead,” adds the analyst, who cites building traction in Agentforce and Data Cloud, ramping sales capacity and accelerating pipeline growth. The firm maintains an Overweight rating and $405 price target on Salesforce shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRM:
- Salesforce price target lowered to $340 from $400 at Deutsche Bank
- Salesforce’s Strong Q2 Performance and AI Growth Drive Buy Rating
- Salesforce: Strategic AI Advancements and Revenue Growth Drive Buy Rating
- Salesforce price target lowered to $300 from $350 at Canaccord
- Salesforce price target lowered to $315 from $335 at Piper Sandler